Guillain-?Barr Syndrome is a rare condition in which a person's immune system attacks the peripheral nerves. People affected suffer from muscle weakness and paralysis. A research team led by ETH ...

GBS is a disease in which a patient’s immune system mistakenly starts attacking the peripheral nervous system.

Hansa Biopharma, “Hansa”, today announced positive high-level data from the 15-HMedIdeS-09 phase 2 trial that demonstrated imlifidase was safe and well tolerated when administered prior to standard of ...

Guillain-Barré Syndrome (GBS) is a rare yet potentially life-threatening neurological condition recently reported in parts of ...

"Unfortunately, two patients have died. Two other patients were kept on life support, and their condition is now out of danger," he said. What is GBS GBS is a disease in which a patient's immune ...

Annexon (ANNX) announced topline results from a real-world evidence study supporting ANX005 as a potential treatment for Guillain-Barre Syndrome. GBS is a rapid-onset and acute neuromuscular disease ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...

Patients with Guillain- Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness.